首页 | 本学科首页   官方微博 | 高级检索  
     

人乳头瘤病毒L1壳蛋白预测宫颈上皮内瘤变患者预后的研究
引用本文:刘丽,陈育梅,张庆元. 人乳头瘤病毒L1壳蛋白预测宫颈上皮内瘤变患者预后的研究[J]. 全科医学临床与教育, 2014, 0(4): 374-376
作者姓名:刘丽  陈育梅  张庆元
作者单位:温州市人民医院妇产科,浙江温州325000
基金项目:温州市科技局课题(Y20130131)
摘    要:
目的探讨宫颈上皮内瘤变(CIN)患者治疗前人乳头瘤病毒(HPV)-L1壳蛋白的表达能否成为预测治疗后疾病转归的指标。方法通过免疫组化法检测CIN患者治疗前HPV-L1壳蛋白表达,把CIN患者分为两组:CINⅠ级组、CINⅡ~Ⅲ级组。治疗后12个月通过导流杂交基因芯片技术检测高危型人乳头瘤病毒(HR-HPV)DNA的表达。结果治疗前CINⅠ的涂片中HPV-L1壳蛋白阳性表达率为75.00%,CINⅡ~Ⅲ的涂片中HPV-L1壳蛋白阳性表达率为36.13%,两者比较差异有统计学意义(χ2=15.43,P<0.05)。CINⅠ级组:术前HPV-L1壳蛋白阳性的患者在术后12个月随访过程中,HR-HPV持续感染阳性率为0%,而术前HPV-L1壳蛋白阴性的患者,术后HR-HPV持续感染阳性率为25.00%。两者比较差异有统计学意义(χ2=6.40,P<0.05);CINⅡ~Ⅲ级组:术前HPV-L1壳蛋白阳性的患者,术后12个月随访过程中,HR-HPV持续感染阳性率为2.33%;而术前HPV-L1壳蛋白阴性的患者,术后HR-HPV持续感染阳性率为22.37%。两者比较差异有统计学意义(χ2=6.44,P<0.05)。结论 CIN患者治疗前HPV-L1壳蛋白的检测有可能成为评估CIN患者治疗后预测疾病转归的指标。

关 键 词:人乳头瘤病毒L1壳蛋白  宫颈上皮内瘤变  高危型人乳头瘤病毒

Research of human papillomavirus-L1 capsid protein for prognosing cervical intraepithelial neoplasia
LIU Li,CHEN Yumei,ZHANG Qingyuan. Research of human papillomavirus-L1 capsid protein for prognosing cervical intraepithelial neoplasia[J]. clinical education of general practice, 2014, 0(4): 374-376
Authors:LIU Li  CHEN Yumei  ZHANG Qingyuan
Affiliation:(Department of Gynecology and Obstetrics, The People' s Hospital of Wenzhou, Wenzhou 325000, China)
Abstract:
Objective To investigate whether detecting human papillomavirus (HPV)-L1 capsid protein can predict the prognosis of cervical intraepithelial neoplasia (CIN) patients or not. Methods HPV-L1 capsid protein expression in pa-tient with CIN before treatment was detected through Immunocytochemical method. And then CIN patients were divided into CINⅠgroup and CINⅡ~Ⅲgroup. The expression of High-risk HPV (HR-HPV) at twelve months after treatment was detect through PCR technology. If detection of HR-HPV was positive which means HR-HPV was persistent infection. Re-sults The positive expression rate of HPV capsid protein was 75.00%in CINⅠgroup and 36.13%in CINⅡ~Ⅲgroup be-fore treatment, the difference was statistical significantly(χ2=15.43,P〈0.05). Persistent infection rate of HR-HPV was 0%at 12 months after treatment in HPV-L1 capsid protein positive expression patients of CINⅠgroup and 25.00%in HPV-L1 capsid protein negative expression patients of CINⅠgroup, the difference was statistical significantly (χ2=6.40,P〈0.05) . Persistent infection rate of HR-HPV was 2.33%at 12 months after treatment in HPV-L1 capsid protein positive expression patients of CINⅡ~Ⅲ group and 22.37% in HPV-L1 capsid protein negative expression patients of CINⅡ~Ⅲ group, the difference was statistical significantly (χ2=6.44,P〈0.05). Conclusion HPV-L1 capsid protein can predict the prognosis of CIN patients to some extent.
Keywords:human papillomavirus-L1 capsid protein  cervical intraepithelial neoplasia  high-risk human papillo-mavirus
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号